Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.

Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.

The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients. A total of 120 patients with HBeAg-positive chronic hepatitis were treated w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ming Shi, Wan-Li Sun, Yan-Yan Hua, Bo Han, Long Shi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0117741&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA
by: Deok-Hwa Seo, et al.
Published: (2024-12-01)

Experience of entecavir therapy in chronic hepatitis B
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Giuseppe Vittorio Luigi De Socio, et al.
Published: (2011-03-01)

Severe Acute Hepatitis B Treated with Entecavir
by: Andrea Tosti, et al.
Published: (2011-01-01)

Adherence to entecavir for chronic hepatitis B and correlation with effectiveness
by: Vanessa Romero Díaz-Maroto, et al.
Published: (2015-11-01)

Augmented epigenetic repression of hepatitis B virus covalently closed circular DNA by interferon-α and small-interfering RNA synergy
by: Kongying Hu, et al.
Published: (2024-12-01)

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
by: Jem Ma Ahn, et al.
Published: (2015-01-01)

Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B
by: Hideo Takayama, et al.
Published: (2021-01-01)

Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome
by: Sheng-Tao Cheng, et al.
Published: (2025-07-01)

Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
by: Elena S Kim, et al.
Published: (2022-06-01)

Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formation.
by: Hu Zhang, et al.
Published: (2025-02-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Determining Hepatitis B Serology After Immune Prophylaxis in Babies of Hepatitis B Surface Antigen Positive Mothers
by: Emine Tekin, et al.
Published: (2021-09-01)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016-07-01)

Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”
by: Long-Shan Ji, et al.
Published: (2022-01-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)

Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria
by: Michael O Iroezindu, et al.
Published: (2013-12-01)

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis
by: Shi-Jia Liu, et al.
Published: (2025-02-01)

Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
by: Takuya Matsubara, et al.
Published: (2025-01-01)

Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis.
by: Weixia Ke, et al.
Published: (2014-01-01)

Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
by: Phaedra M Tachtatzis, et al.
Published: (2015-01-01)

Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China
by: Min Wang, et al.
Published: (2015-07-01)

Knowledge and behaviors about hepatitis B prevention and control among carriers of hepatitis B surface antigen
by: LI Siwen, ZHOU Tiantian, ZHANG Chao, ZHANG Dan, HU Weijun
Published: (2025-03-01)

Correction: Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
by: Phaedra M Tachtatzis, et al.
Published: (2015-01-01)

Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus
by: Kasha P. Singh, et al.
Published: (2025-07-01)

Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice
by: Xiaofang Li, et al.
Published: (2025-05-01)

Relationship of serum hepatitis B Virus DNA levels with Hepcidin, Pentraxin-3, Zonulin, and Copeptin in chronic hepatitis B patients
by: Burak Ezer, et al.
Published: (2025-04-01)

Dynamic predicting hepatitis B surface antigen decline rate during treatment for patients with chronic hepatitis B
by: Ying Xin, et al.
Published: (2025-09-01)

Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
by: Jianhong Chen, et al.
Published: (2016-01-01)

Sirtuin 2 inhibitor AGK2 exerts antiviral effects by inducing epigenetic suppression of hepatitis B virus covalently closed circular DNA through recruitment of repressive histone lysine methyltransferases and reduction of cccDNA
by: Jumi Kim, et al.
Published: (2025-04-01)

Pregnancy and Hepatitis B Virus Infection
by: Selma TOSUN
Published: (2016-12-01)

HEPATITIS B VIRUS AND RHEUMATIC DISEASES
by: B. S. Belov, et al.
Published: (2020-04-01)

Mutational landscape of the surface antigen of hepatitis B virus in patients with hepatocellular carcinoma
by: Arwa Bagasi, et al.
Published: (2025-06-01)

Liver cancer: expression features of hepatitis B antigens
by: V. A. Tumanskiy, et al.
Published: (2013-12-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Depression and anxiety in chronic hepatitis B: effect of hepatitis B virus infection on psychological state in childhood
by: Nur Arslan, et al.
Published: (2003-01-01)